Category Archives: Science Research Technology

Science Research Technology

Innovative 3D Software in Additive Manufacturing

Innovative 3D Software in Additive Manufacturing

(Source: CoreTechnologie GmbH)

The German-French software producer CoreTechnologie is presenting its new 3D additive manufacturing software at this year’s trade fair Formnext. With the innovative tool, CAD data of all common formats for 3D printing processes can be processed and analyzed with special test profiles with regard to the different rapid manufacturing procedures.

Data Processing with B-Rep Solids

Especially for metal printing processes, the new 3D additive manufacturing software can be used to create support structures for production as well as latice geometries for lightweight construction and material savings. The CAD models can be used as intelligent B-Rep geometry by robust direct modeling functions, which has significant advantages over the machining of tessellated models. The clear graphic interface of the system allows a direct and easy modification of critical geometry areas as well as the reduction of the complexity of the parts to be printed.

Optimal Utilization of the Installation Space

By freely selectable slicing parameters, the roughness is displayed and the components can be automatically positioned by the system in such a way that selected areas have the best possible surface. The database contains standard machine types with their building spaces. Intelligent nesting functions ensure fast simple filling for optimal utilization of the building space and thus maximum efficiency.

Flexibility and Data Quality

The 3D additive manufacturing software has sophisticated interfaces for CATIA, NX, SolidWorks, Creo, JT, STEP and many more. The healing functions of the system ensure the best possible data quality of the converted models optimized for 3D printing, which can be stored in the amf, 3mf and stl formats. This ensures that quality mesh models are sent to the printer.

The innovative 3D software will be presented to interested parties at the trade fair Formnext from November 14th to 17th, 2017 in Frankfurt in Hall 3.0 at booth C68.

For further information, please visit www.coretechnologie.com
+++

Since its foundation in 1998, the software manufacturer CoreTechnologie with locations in Germany, France, USA, Japan and Great Britain has been led by the managing directors Dominique Arnault and Armin Brüning. With innovative products, the visionary company has consistently optimised its product portfolio and secured the technological leadership in the area of conversion software. Each year, CoreTechnologie invests more than 30 per cent of sales in the research and implementation of new technologies and has the most complete product range in this field.

In the focus of technology development is the product line of „3D Evolution“ which guarantees efficient and lossless exchange of complex data structures between independent and heterogeneous CAX software solutions. With extremely powerful native interfaces for all leading CAD systems and for conversion of all common 3D formats, the software module ensures optimal interoperability of most various IT solutions.

Apart from providing visualisation and manufacturing data across most various systems, CoreTechnologie offers outstanding technologies for automatic data correction, feature-based conversion, geometry optimisation, quality control and long-time archiving as well as for visualisation of complex 3D models. The software components for software manufacturers of the most different CAX applications are the company“s second leg.

The customer portfolio of CoreTechnologie comprises more than 400 companies from the automotive, aerospace, engineering and consumer goods industry who are in many cases the quality leaders in their relevant segment.

Company-Contact
Core Technologie GmbH
Armin Brüning
Klinger 5
63776 Mömbris
Phone: 0049 6029 98 999 10
E-Mail: info@de.coretechnologie.com
Url: http://www.coretechnologie.com

Press
PR Solutions by Melanie Schacker
Melanie Schacker
Am Nonnenhof 55
60435 Frankfurt/Main
Phone: 0049 69 95 20 8991
Fax: 0049 69 95 20 8992
E-Mail: presse@pr-schacker.de
Url: http://www.pr-schacker.de

Science Research Technology

Digital length gauges by WayCon – extremely accurate and versatile

Digital length gauges by WayCon - extremely accurate and versatile

Digital Length Gauges ST and MT

WayCon Positionsmesstechnik has added digital length gauges from the HEIDENHAIN SPECTO (ST) and METRO (MT) series to its product range. The length gauges feature an outstanding accuracy of up to +/-0.2 μm over measuring ranges up to 30 mm. Waycon length gauges have many versatile applications, as the plungers can be actuated pneumatically or by the measured object. They are suitable for use in production metrology, multipoint inspection stations, measuring equipment monitoring, or as position encoders.

The digital length gauges are quick, reliable, and accurate. Their robust design and high thermal stability allows them to also be used in production equipment and machines. The SPECTO range has an IP rating of up to IP67.

Their compact structure allows for several gauges to be combined effectively to simultaneously measure different points of an object. The incremental output signal produced by the gauge can be directly connected to a PLC or the measured values can be displayed on a digital readout (DRO) on site.

For more information please visit: www.waycon.biz/products/digital-gauges/

WayConPositionsmesstechnik GmbH has been developing and manufacturing precision sensors for position and distance measurement since 1999. As an innovative company with headquarters in Taufkirchen near Munich and a branch in Brühl near Cologne, we sell our products all over the world. Our goal is to provide our customers with the best possible measurement technique solution: from high-quality sensors from the standard range to customer-specific solutions, from prototype to series production – for the most varied applications in industry and research. The products made in Taufkirchen are subject to rigorous quality standards and every single one is delivered to our customers with a calibration certificate.

Company-Contact
Waycon Positionsmesstechnik GmbH
Marcus Venghaus
Mehlbeerenstr 4
82024 Taufkirchen
Phone: 089-67-9713-0
E-Mail: info@waycon.de
Url: http://www.waycon.biz

Press
Waycon Positionsmesstechnik GmbH
Marcus Venghaus
Mehlbeerenstr. 4
82024 Taufkirchen
Phone: +49 89 679713-0
E-Mail: presse@waycon.de
Url: http://www.waycon.biz

Science Research Technology

ERN-EYE: a European reference network dedicated to rare eye diseases

7th SIOG congress of the Italian Society for Genetic Ophthalmology

ERN-EYE: a European reference network dedicated to rare eye diseases

(Source: Retina Implant AG)

(Reutlingen/Naples) – The congress of the Italian Society for Genetic Ophthalmology (SIOG) was a prime example of successful collaboration. For this year’s event, medical professionals and scientists met in Naples to discuss research and treatments for rare eye diseases at a European level. Topics included collaboration within the ERDC (European Retinal Disease Consortium) and ERN-EYE, a European reference network dedicated to rare eye diseases. Prof. Eberhart Zrenner, who has been an internationally renowned specialist in the research and treatment of rare eye diseases for many years now, gave a presentation on neuro-stimulation and the effects of transepithelial electro-stimulation on the sight of patients with retinitis pigmentosa.

At this year’s congress of the Italian Society for Genetic Ophthalmology („Congresso SIOG – Società Italiana di Oftalmologia Genetica“) in Naples, Italy, specialists in rare eye diseases met to discuss research results and treatments, as well as new and existing opportunities for cooperation at a European level. To improve cross-border treatment and care for patients with rare eye diseases, the European Union and the member states launched 23 European Reference Networks (ERNs) at the start of 2017. Retina Implant AG welcomes and supports the development of the European Reference Network for Rare Eye Diseases (ERN-EYE).

The members of the network all have extensive experience in researching and treating rare eye diseases. The aim is to promote knowledge transfer between ERN experts and doctors, who will be able to query a database to find out for their patients which special treatment options are available for the relevant condition and where. „To support this Europe-wide patient referral system, treatment reimbursement should be regulated and harmonised on a transnational basis,“ explains Reinhard Rubow, CEO of Retina Implant AG. „For instance, a patient from Ireland could have our subretinal optic chip implanted at our implantation centre in Tübingen, and the costs would be reimbursed. ERN provides a framework that will allow future patients to be treated at the location in Europe that is most suitable for them.“

Working with patient associations such as Retina International is considered to be essential here, and the organisation’s president, Christina Fasser, raised the issue of patient perspective in Naples: „We must not leave anyone behind – everyone has a right to the best standards in diagnosis and treatment.“

„These closing words from Christina Fasser precisely reflect our own motivation to continue our research and development work,“ agrees Rubow. „Just recently, the French health authority HAS (Haute Autorite de Sante) approved our Forfait Innovation application to assess the benefits of our RETINA IMPLANT Alpha AMS subretinal implant,“ he adds. The accompanying Retina Implant AG study investigates the impact of the implant on the participants‘ daily lives. For the first time, patient-reported outcome surveys are being used that are specifically adjusted to low-vision patients and their social routines, age, language and life situations. The subretinal implant from Retina Implant AG can help restore partial sight to visually impaired patients who perceive very little or no light as a result of different forms of the degenerative retinal disease retinitis pigmentosa (RP).

In a lecture entitled „Close to the physiology of vision“, Prof. Eberhart Zrenner reported on patients who have had the chip implanted and have thus partially regained the function of degenerated photoreceptors. For instance, they can perceive light sources, which improves spatial orientation. „Clearly, Retina Implant AG not only develops innovative treatments and high-tech products for people who suffer from RP – we also engage with networks and the international scientific community to drive forward research in this area as a whole,“ Rubow sums up.

Retina Implant AG was a major supporter of the event.

About Retina Implant AG
Retina Implant AG researches and develops innovative treatments and high-tech products for people suffering from retinitis pigmentosa (RP). The subretinal RETINA IMPLANT Alpha AMS can help blind patients regain a certain degree of useful sight. The CE-approved microchip is implanted beneath the retina (subretinally) at specialist RI implantation centres.
Transcorneal electrical stimulation (TES treatment) with the RI OkuStim® system offers RP patients with sufficient residual vision the opportunity to slow down the progression of the disease.
The company, based in Reutlingen, employs around 45 people and is managed by Reinhard Rubow (CEO and speaker of the Management Board), Jürgen Klein (Member of the Board, Sales & Marketing) and Dr. Alfred Stett (CTO, Member of the Board).

Company-Contact
Retina Implant AG
Ines Wülker
Gerhard-Kindler-Str. 13
72770 Reutlingen
Phone: + 49 71 21 3 64 03 – 289
E-Mail: ines.wuelker@retina-implant.de
Url: https://www.retina-implant.de/en/

Press
Zeeb Kommunikation GmbH
Anja Pätzold
Hohenheimer Straße 58a
70184 Stuttgart
Phone: 0711-60 70 719
E-Mail: info@zeeb.info
Url: http://www.zeeb-kommunikation.de

Science Research Technology

Definiens broadens Immuno-Oncology service Offer

Washington, D.C., November 08, 2017 – With the start of the
32nd Annual Meeting (November 8th-12th) of the Society for
Immunotherapy of Cancer (SITC) in National Harbor, MD,
Definiens, the leader in Tissue Phenomics® and provider of endto-
end solutions for biomarker programs in immuno-oncology,
unveils its game changing Immuno-Oncology Panel (IO-Panel)
as parts of its groundbreaking new „Insights“-Services
portfolio.
The IO-Panel is a first in class powerful tool in Definiens new portfolio of
modular services. The IO-Panel empowers pharmaceutical immunooncology
(IO) researchers to advance tissue-biomarker-dependent drug
development and to speed up transfer to clinical research. Future
advancements in immuno-oncology depend on broader use of
standardized biomarkers for multiple treatment programs.
„The IO-Panel helps to harmonize and standardize the understanding on
the entire cancer Immune-landscape through an extendable set of seven
core biomarkers in combination with Definiens“ first in class Tissue-
Phonemics®-driven Image analysis services. It helps to remove
uncertainties and to accelerate that patients and healthcare systems
benefit faster from new precision therapies in immuno-oncology.“
comments Ralf Huss, Chief Medical Officer of Definiens.
Thomas Heydler, Chief Executive Officer of Definiens explains further:
„Definiens“ tailored end-to-end solution allows drug researchers to
develop predictive multi-biomarkers based on a defined standard to derisk
trial investments as well as efforts. It will help to accelerate immunooncology
drug development and more effective clinical trials“.
The IO-Panel combines Definiens“ leading digital image analysis
capabilities, powered by Tissue-Phenomics® technology and high-end
consulting services, delivered by a leading team of expert consultants.
Tissue-Phenomics® technology can quantify the relevant spatial relations
of different immuno and tumor cells within the context of the complete
tissue architecture and tumor heterogeneity. By correlating this
information with e.g. patient data, Definiens“ experts generate biological
insights that are needed for true precision medicine.
The IO-Panel is available through Definiens“ new and unique web-based
service platform known as „Insights“. It allows clients to easily access
Definiens“ entire Services portfolio and acts as a central data repository
which supports the collaboration with internal and external stakeholders
in a regulatory compliant environment.
„Definiens“ new modular service portfolio is a milestone for biomarkerdependent
drug development. Harmonizing biomarkers in pre-clinical and
clinical trial programs and adding multi-omics and treatment-data assures
data consistency and learnings across drug projects and indications. „
adds Heinz Oehl, VP Global Marketing and Corporate Business
Development at Definiens.
Definiens once again proves to be a main engine of innovation in immunooncology
and a key partner with expertise to support tissue-based
oncology biomarker programs from start to finish.
Please attend at The Society for Immunotherapy of Cancer’s (SITC) 2017
Pre-Conference „Immuno-Oncology Biomarkers: Today“s Imperatives for
Tomorrow“s Needs“ in National Harbor, MD, our presentation „Multiplex
IHC Immuno-Oncology Panel for Standardized Profiling of the Immune
Status Based on Spatial and Functional Characterization of the Tumor
Microenvironment“ on November 8, 2017 to learn more about the
comprehensive assessment of the immune status provided by Definiens“
IO Panel image and data analysis based on multiplex IHC assays provided
by Mosaic Laboratories, LLC., or visit us at the Definiens congress booth.

About Definiens
Improving patient lives by unlocking the tissue phenome
In oncology, therapeutic strategies have shifted from a direct assault on cancer cells to recruiting the immune
system for that purpose. Our mission is to accelerate breakthroughs in immuno-oncology by helping
pharmaceutical researchers better leverage tissue-based information through Definiens Tissue Phenomics® –
technology. Our expertise accelerates and deepens understanding of disease biology and immune system
mechanisms and allows to bring multi-omics data into a cancer-relevant context, which facilitates the
translation of new insights into novel therapies and treatment strategies. Our vision is to create unique and
actionable patient profiles through harmonized biomarkers for an individualized standard of care, where
patients experience fewer side effects and live longer. Definiens“ proven technology has been used in
thousands of projects, yielding results that have accelerated drug development and produced over 650 peerreviewed
publications.
Definiens is a member of the AstraZeneca group providing products and services to companies across the life
sciences sector, including MedImmune, the global biologics research and development arm of AstraZeneca.
Definiens‘ Tissue Phenomics approach was awarded the 2013 Frost and Sullivan Company of the Year Award
for Global Tissue Diagnostics and Pathology Imaging. For more information, please visit: www.definiens.com
Safe Harbor Statement
This press release contains „forward-looking statements“ within the meaning of the Private Securities Litigation
Reform Act of 1995, including statements relating to data being presented at the at the 2017 Society for
Immunotherapy of Cancer (SITC) held November 10-11, 2017 in National Harbor, MD. These „forward-looking
statements“ are based on management’s current expectations of future events and are subject to a number of
risks and uncertainties that could cause actual results to differ materially and adversely from those described
or implied in the forward-looking statements.

Contact
Definiens AG
Heinz Oehl
Bernhard-Wicki-Straße 5
80636 München
Phone: +49 (0) 89 231180-00
E-Mail: press@definiens.com
Url: http://www.definiens.com

Science Research Technology

SKIDATA Innovathon: exploring digital trends

Employees and students develop new solutions for IT & SKIDATA technology

SKIDATA Innovathon: exploring digital trends

SKIDATA Innovathon: exploring digital trends

It´s that time again – namely, for the next round of the SKIDATA Innovathon. Experienced specialists, creative outside-the-box thinkers and inspiring newcomers will develop practical applications for SKIDATA´s digital future as part of the third SKIDATA Innovathon taking place from November 8-10, 2017. Anything goes at this event – anything except conventional ideas, that is. From big data to virtual reality or artificial intelligence: removed from everyday work, more than ten international teams from all divisions will work on fresh, new concepts. Because together we create the best ideas.

„At SKIDATA, we have employees with many creative ideas and a strong pioneering spirit. With the Innovathon, we want to give them the chance to develop and utilize this power of innovation in an inspiring think tank atmosphere and in interdisciplinary teams“, explains Wolfgang Titze, Head of Software Development in Salzburg and co-organizer of the SKIDATA Innovathon. In addition to being a think tank for the company, however, this event has a social component which is also very valuable. Working together on an idea for days unites us.

Innovation is a result of professional teamwork

This is the third time the Innovathon has taken place and it has already established itself as an internal forum for innovation. Each year the number of participants has grown. Participants all have a knack for technology and plenty of unconventional ideas in their mind, and work in teams of three or four. With an open mind and enthusiasm for new things, they develop exciting concepts that no one has thought of before, making the teams grow closer together. „The best part of the Innovathon is that it harnesses the impressive knowledge and inventive spirit of SKIDATA team members to bring ideas to life and help shape the future of the company“, says Jeff, participant from the USA at this year´s SKIDATA Innovathon.

Research & development: inventiveness at SKIDATA

At SKIDATA, innovation is practically in our blood. Günther Walcher started the operative business in 1977 with the first printed ski ticket. What began as an idea 40 years ago has since developed into an internationally successful digital solution provider in access and visitor management. Still today, it is our employees´ pioneering spirit that drives the development of our IT business solutions forward. The result? SKIDATA has more than 100 patent families that have been developed and filed by the approximately 60 inventors in the SKIDATA team. Continuous research and development, a good work atmosphere that creates freedom for innovation and events such as the SKIDATA Innovathon make it possible. Our employees´ power of innovation is central to SKIDATA and new patent ideas are awarded once a year as part of a recognition event by the Executive Board.

Anyone with a keen eye for digital trends who is interested in working in SKIDATA´s creative and state-of-the-art environment can find job vacancies by visiting: https://www.skidata.com/en/corporate/jobs-careers/job-vacancies-at-skidata/

Note: The publication is accepted until 06.02.2018.

SKIDATA is a leading international company for access solutions and management. More than 10,000 SKIDATA installations in ski resorts, sports stadiums, major airports, shopping centers, cities, spas and wellness facilities, exhibition centers and amusement parks worldwide ensure safe and reliable access control for people and vehicles. SKIDATA places great value in offering solutions that are intuitive, easy to operate and secure. With their integrated concepts, SKIDATA helps clients optimize performance and maximize profits. The SKIDATA Group ( www.skidata.com) is a member of the publicly traded Swiss Kudelski Group ( www.nagra.com), a leading provider of digital security solutions.

Contact
SKIDATA AG
Mag. Belkis Etz
Untersbergstraße 40
5083 Grödig/Salzburg
Phone: +43 6246 888-0
E-Mail: jobs@skidata.com
Url: https://www.skidata.com/en/corporate/jobs-careers/

Science Research Technology

Asahi Kasei“s Microza™ hollow-fiber membrane selected for desalination plant in Kuwait

The company“s largest order for water filtration membranes

Dusseldorf, October 30, 2017 – Microza™ Dusseldorf, October 30, 2017 – Microza™ hollow-fiber membrane for water treatment from Asahi Kasei was selected as pretreatment membrane for the Doha Phase 1 reverse osmosis (RO) seawater desalination plant to be built near Kuwait City by Doosan Heavy Industries and Construction, a major Korean plant construction company. Reverse Osmosis is a method of producing fresh water by removing salt ions from seawater with a special membrane at high pressure.

The Asahi Kasei membrane treatment capacity for this project is scheduled to be 610,000 tons per day, representing the largest hollow-fiber filtration membrane order received by Asahi Kasei.

Many RO plants for seawater desalination are planned in Kuwait and other countries of the Middle East to address chronic shortages of fresh water, with microfiltration (MF) and ultrafiltration (UF) membranes including Asahi Kasei“s Microza™ being adopted as pre-treatment membrane.

In addition to being widely used around the world in the fields of potable water production, wastewater treatment, and water recycling, Microza™ has a growing track record as pre-treatment membrane for RO in the Middle East. Microza™ was selected for the Doha Phase 1 Plant in recognition of its outstanding performance and reliable operation, and Asahi Kasei will actively continue to focus on meeting growing demand in the Middle East.

Outline of the Doha Phase 1 Plant

LocationDoha, Kuwait City, Kuwait
Capacity610,000 tons/day (Asahi Kasei membrane)
ConcessionaireKuwait Ministry of Electricity and Water
ContractorDoosan Heavy Industries and Construction Co., Ltd.

About Microza™
Based on Asahi Kasei“s original membrane-formation technology, Microza™ hollow-fiber membrane made of polyvinylidene fluoride (PVDF) exhibits outstanding physical strength and chemical resistance, with high filtration performance as well as long-term durability in water treatment applications exceeding competing PVDF membranes. Asahi Kasei is one of the world“s leading suppliers of hollow-fiber membrane and systems for water treatment, with its Microza™ membrane used at over 1,600 plants worldwide. In the United States market for membrane-process potable water clarification systems, the world“s largest, Microza™ holds the leading share. Adoption of Microza™ has also been growing firmly in many countries which face water shortages and growing needs for improved water quality, including China, Korea, Singapore, Thailand, Indonesia, and Middle Eastern countries. Asahi Kasei will continue to contribute to solutions for a wide range of environmental problems related to water resources throughout the world.

About Asahi Kasei
The Asahi Kasei Corporation is a globally active technology company with operations in the Material, Homes, and Health Care business. The Material division encompasses fibers & textiles, petrochemicals, performance polymers, performance materials, consumables, battery separators, and electronic devices. The Homes division provides housing and construction materials to the Japanese market. The Health Care division includes pharmaceuticals, medical devices, and acute critical care devices and systems. With approximately 34,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries.

Asahi Kasei is „Creating for Tomorrow“ with all operations sharing a common mission of contributing to life and living for people around the world with sustainable products and technologies.

For more information, please contact:

http://www.asahi-kasei.co.jp/asahi/en/

https://www.asahi-kasei.eu/

Company contact
Asahi Kasei Europe GmbH
Sebastian Schmidt
Am Seestern 4
40547 Düsseldorf
Phone: +49 (0)211 280 68 139
E-Mail: Sebastian.Schmidt@asahi-kasei.eu

Press contact
financial relations GmbH
Henning Küll
Louisenstraße 97
61348 Bad Homburg
Telefon: +49 (0) 6172 27159 12
Phone: +49 (0) 175 903 42 29
E-Mail: h.kuell@financial-relations.de

for water treatment from Asahi Kasei was selected as pretreatment membrane for the Doha Phase 1 reverse osmosis (RO) seawater desalination plant to be built near Kuwait City by Doosan Heavy Industries and Construction, a major Korean plant construction company. Reverse Osmosis is a method of producing fresh water by removing salt ions from seawater with a special membrane at high pressure.

The Asahi Kasei membrane treatment capacity for this project is scheduled to be 610,000 tons per day, representing the largest hollow-fiber filtration membrane order received by Asahi Kasei.

Many RO plants for seawater desalination are planned in Kuwait and other countries of the Middle East to address chronic shortages of fresh water, with microfiltration (MF) and ultrafiltration (UF) membranes including Asahi Kasei“s Microza™ being adopted as pre-treatment membrane.

In addition to being widely used around the world in the fields of potable water production, wastewater treatment, and water recycling, Microza™ has a growing track record as pre-treatment membrane for RO in the Middle East. Microza™ was selected for the Doha Phase 1 Plant in recognition of its outstanding performance and reliable operation, and Asahi Kasei will actively continue to focus on meeting growing demand in the Middle East.

Outline of the Doha Phase 1 Plant

Location
Doha, Kuwait City, Kuwait
Capacity
610,000 tons/day (Asahi Kasei membrane)
Concessionaire
Kuwait Ministry of Electricity and Water
Contractor
Doosan Heavy Industries and Construction Co., Ltd.

About Microza™
Based on Asahi Kasei“s original membrane-formation technology, Microza™ hollow-fiber membrane made of polyvinylidene fluoride (PVDF) exhibits outstanding physical strength and chemical resistance, with high filtration performance as well as long-term durability in water treatment applications exceeding competing PVDF membranes. Asahi Kasei is one of the world“s leading suppliers of hollow-fiber membrane and systems for water treatment, with its Microza™ membrane used at over 1,600 plants worldwide. In the United States market for membrane-process potable water clarification systems, the world“s largest, Microza™ holds the leading share. Adoption of Microza™ has also been growing firmly in many countries which face water shortages and growing needs for improved water quality, including China, Korea, Singapore, Thailand, Indonesia, and Middle Eastern countries. Asahi Kasei will continue to contribute to solutions for a wide range of environmental problems related to water resources throughout the world.

About Asahi Kasei
The Asahi Kasei Corporation is a globally active technology company with operations in the Material, Homes, and Health Care business. The Material division encompasses fibers & textiles, petrochemicals, performance polymers, performance materials, consumables, battery separators, and electronic devices. The Homes division provides housing and construction materials to the Japanese market. The Health Care division includes pharmaceuticals, medical devices, and acute critical care devices and systems. With approximately 34,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries.

Asahi Kasei is „Creating for Tomorrow“ with all operations sharing a common mission of contributing to life and living for people around the world with sustainable products and technologies.

For more information, please contact:

http://www.asahi-kasei.co.jp/asahi/en/

https://www.asahi-kasei.eu/

Company contact
Asahi Kasei Europe GmbH
Sebastian Schmidt
Am Seestern 4
40547 Düsseldorf
Phone: +49 (0)211 280 68 139
E-Mail: Sebastian.Schmidt@asahi-kasei.eu

Press contact
financial relations GmbH
Henning Küll
Louisenstraße 97
61348 Bad Homburg
Telefon: +49 (0) 6172 27159 12
Phone: +49 (0) 175 903 42 29
E-Mail: h.kuell@financial-relations.de

The Asahi Kasei Group is a diversified group of companies led by Asahi Kasei Corp., with operations in the Material, Homes, and Health Care business sectors. Asahi Kasei distributes its innovative technologies and unique materials on markets worldwide.
With more than 30,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. Asahi Kasei is „Creating for Tomorrow“ with all operations sharing a common mission of contributing to life and living for people around the world.

Company-Contact
Asahi Kasei Europe GmbH
Sebastian Schmidt
Am Seestern 4
40547 Düsseldorf
Phone: +49 (0)211 280 68 139
E-Mail: Sebastian.Schmidt@asahi-kasei.eu
Url: https://www.asahi-kasei.eu/

Press
financial relations GmbH
Henning Küll
Louisenstraße 97
61348 Bad Homburg
Phone: +49 (0) 6172 27159 12
E-Mail: h.kuell@financial-relations.de
Url: http://www.financial-relations.de

Science Research Technology

CeramOptec adds splicing applications to its portfolio

High precision fusion splicing of end caps and optical fibers

CeramOptec adds splicing applications to its portfolio

Fiber cables with ferrules (Source: @ CeramOptec GmbH)

Bonn, October 11, 2017 – CeramOptec, the specialist for multimode optical fibers, manufactured from quartz glass, has added splicing applications to its product portfolio. Based on the utilization of the CO2-Laser-Systems Nyfors SmartsplicerTM, in whose development CeramOptec participated directly, the biolitec subsidiary from Bonn is, as of now, able perform high precision, individually customized fusion splicing of end caps and various optical fibers. The software controlled splicing system is built based on the patented Axicon SplicingTM beam formation technology and projects a ring-shaped laser focal point, whose diameter can be adjusted according to the respective application. The energy from the laser is distributed evenly and projected precisely on the intended splicing area. This way, especially end caps with larger radii can be fused to a fiber through the laser much more precise and efficient than by means of conventional splicing devices. The system is also particularly well suited for the splicing of photonic crystal and gradient index fibers. Applications like the active collapsing of fibers, as well as rounding off and tapering of fiber ends can be achieved with the new splicing laser with previously unobtainable precision. The very stable software control and high precision of all optical and mechanical components guarantee the exact reproducibility of production results, even in highly demanding manufacturing processes. In order to accomplish the demand-oriented configuration of the application at all times, CeramOptec is available to assist customers through extensive guidance and test-runs within their own production process.

The SmartsplicerTM was developed as the result of a research project, in which aside from Nyfors and CeramOptec, also the Fraunhofer-Institut für Angewandte Optik und Feinmechanik (IOF) [Fraunhofer Institute for Applied Optics and Precision Engineering] in Jena participated. While Nyfors developed the laser system and Fraunhofer IOF the optical components, CeramOptec was in charge of consistently testing the individual application scenarios. Additional information about CeramOptec“s fusion splicing portfolio, as well as the guidance and test offer, are available online at www.ceramoptec.com

About CeramOptec
CeramOptec specialises in the production of multimode optical fibres made of quartz glass. Founded in 1988, today this medium-sized company is a subsidiary of biolitec AG, one of the world’s leading medical technology companies in the field of laser applications. With offices in China and distribution partners in the USA, India, Japan and Korea, CeramOptec is strongly represented not only in Europe, but also in the Asian and North American markets. The company“s product portfolio includes fibers, fiber bundles, assemblies and cables for a wide range of applications, including industrial and medical laser applications, aerospace sensor systems and spectroscopic applications in astronomy and the chemical industry. A special feature is the manufacture of glass fiber cores with rectangular through to octagonal geometry (Non Circular Core Fibres/NCC), which are used especially in astrophysics. The biolitec group employs a total of 245 people.

Company-Contact
CeramOptec GmbH
Holger Bäuerle
Brühler Straße 30
53119 Bonn
Phone: +49 (0) 228 / 97 967-12
Fax: +49 (0) 228 / 97 967-99
E-Mail: holger.baeuerle@ceramoptec.com
Url: http://www.ceramoptec.com

Press
fr financial relations gmbh
Jörn Gleisner
Louisenstraße 97
61348 Bad Homburg
Phone: +49 61 72 / 27 15 9 – 20
E-Mail: j.gleisner@financial-relations.de
Url: http://www.financial-relations.de/cms/front_content.php

Science Research Technology

Experts on hand to answer patients‘ questions

First retinitis pigmentosa patient day organised by university eye hospital is a great success

Experts on hand to answer patients

Retinitis pigmentosa patient day: Prof. E. Zrenner, PD Dr. K. Stingl, P. Böhm (from right) (Source: Retina Implant AG/Bernhard Krause)

(Reutlingen/Tübingen) – The first retinitis pigmentosa patient day at the ophthalmology department of the University Eye Hospital in Tübingen was a great success. Last Saturday, under the banner „Meet the Experts“, world-renowned specialists offered blind and visually impaired people and their families an overview of the latest research. Patients being treated using transcorneal electrical stimulation or who have received an electronic retinal implant gave first-hand accounts of their experiences.

„Tomorrow sees the start of the „Week of Sight“,“ said Prof. Eberhart Zrenner, welcoming visitors to the first retinitis pigmentosa patient day in Tübingen last Saturday. This exceptional event, hosted by the Centre for Rare Diseases (ZSE) at the University Eye Hospital’s ophthalmology department, fitted perfectly into the Germany-wide campaign that brings together activities under the key theme of „Understanding and preventing blindness“ from 8 to 15 October 2017. Over 500 participants, visually impaired people and their families came along to Tübingen. Due to the high level of interest, the proceedings had to be moved to a much larger auditorium near the new University Eye Hospital in Tübingen before the event got under way.

The slogan of the patient day – „Meet the Experts“ – more than lived up to its name. Prof. Zrenner, Dr. Katarina Stingl, Prof. Karl Ulrich Bartz-Schmidt, Dr. Andreas Schatz and Prof. Dominik Fischer – internationally renowned specialists from medicine and research at the University Hospital of Tübingen – came together to answer participants‘ questions in person.

Dr. Stingl, who is responsible for surgery for congenital retinal diseases at the University Eye Hospital in Tübingen as Prof. Zrenner’s successor, won the 2017 Retinitis Pigmentosa Research Prize from the PRO RETINA Deutschland patient association just a few days prior to the event. Among other things, she spoke about the latest studies on retinal implants. Retinal implants can help some blind patients regain part of their sight. Prof. Fischer informed visitors about the possibilities offered by gene therapy, although these are still in the study phase. Prof. Bartz-Schmidt, the Medical Director of the University Eye Hospital in Tübingen and one of the world’s few specialists who can perform this operation, then explained how a subretinal optic chip is implanted. He also presented other visual protheses that have been implanted in Cologne. The audience listened attentively to the remarks by Prof. Zrenner, too. He described the state of research relating to treatment options for RP. He explained that, depending on the patient and the progression of the disease, a decision has to be made on whether prevention, retention or restoration is appropriate. Medication-based treatment, gene therapy, electrical stimulation or electronic implants could thus be possible. Dr. Schatz, whose roles include that of study manager in the Experimental Electrophysiology department at the eye hospital, used his presentation „Transcorneal electrical stimulation (TES) – an initial treatment option for RP“ to explain what conditions need to be met to decelerate the progression of retinitis pigmentosa in patients with sufficient residual vision using electrical simulation.

Alongside the presentations by the experts, what made the patient day so extraordinary for patients were the reports by other affected people such as Verena Heier. The 26-year-old RP patient travelled from Cologne to talk about her personal experiences with electrical stimulation: „TES treatment gives me the reassurance of doing something to combat the progression of the disease.“ Having the feeling of being able to do something to fight the disease was also important to Peter Böhm when he had the implant inserted at the age of 47. Böhm, an IT consultant, outlined his experiences with the chip: „The chip helped me to better find my way around in the dark, especially with strong light sources and contrasts. However, this isn’t possible without training.“ Miikka Terho from Finland was introduced by Prof. Zrenner as a true pioneer, because in 2008 he was one of the first patients in the world to be implanted with the chip from Retina Implant. Terho was not only able to read his name, which was laid-out in front of him in 8 cm white letters on a black background, but was even able to correct it: „A man who had until now been blind points out a spelling mistake in his name,“ said Prof. Zrenner, describing the research success, which caused quite a stir at the time. Following successful reimplantation, the completely blind RP patient now wears the enhanced version of the chip – the RETINA IMPLANT Alpha AMS, which has CE certification.

Karin Papp, a representative of self-help organisation PRO RETINA Deutschland e.V., gave a very moving description of how, despite all the advances in medicine, a retinitis pigmentosa diagnosis is still initially a shock. She herself suffers from the condition and described how it feels when a doctor explains to a patient that he or she is suffering from an incurable disease that will lead to destruction of the retina and usually total blindness in the final stage. An unwillingness to accept the apparently inevitable progression of this hereditary degenerative retinal condition certainly acted as an impetus for many of the assembled participants. And even though the experts could not – and would not – promise them any miracles, they were nevertheless able to convey a powerful message that there has never been so much promising research into understanding and preventing blindness.

About Retina Implant AG
Retina Implant AG researches and develops innovative treatments and high-tech products for people suffering from retinitis pigmentosa (RP). The subretinal RETINA IMPLANT Alpha AMS can help blind patients regain a certain degree of useful sight. The CE-approved microchip is implanted beneath the retina (subretinally) at specialist RI implantation centres.
Transcorneal electrical stimulation (TES treatment) with the RI OkuStim® system offers RP patients with sufficient residual vision the opportunity to slow down the progression of the disease.
The company, based in Reutlingen, employs around 45 people and is managed by Reinhard Rubow (CEO and speaker of the Management Board), Jürgen Klein (Member of the Board, Sales & Marketing) and Dr. Alfred Stett (CTO, Member of the Board).

Company-Contact
Retina Implant AG
Ines Wülker
Gerhard-Kindler-Str. 13
72770 Reutlingen
Phone: + 49 71 21 3 64 03 – 289
E-Mail: ines.wuelker@retina-implant.de
Url: https://www.retina-implant.de/en/

Press
Zeeb Kommunikation GmbH
Anja Pätzold
Hohenheimer Straße 58a
70184 Stuttgart
Phone: 0711-60 70 719
E-Mail: info@zeeb.info
Url: http://www.zeeb-kommunikation.de

Science Research Technology

perma STAR VARIO Gen. 2.0

One lubrication system for all types of applications

perma STAR VARIO Gen. 2.0

perma STAR VARIO installed on an electric motor

Euerdorf, Germany – Lubrication plays an important role in maintenance programs. Equipment breakdowns caused by insufficient or incorrect lubrication can have fatal and costly consequences. In some cases they can even stop the entire production. Correct lubrication is therefore a basic requirement for trouble-free operation. The new perma STAR VARIO ensures optimum lubrication regardless of changing temperatures, high counter pressure, or contamination at the lubrication point.

The electromechanical lubrication system was invented 15 years ago and has proven itself in all kinds of industries. The new version offers many improvements: LCD-display with push button control, all around LED lights and a new design.

The LCD-display with push button control is self-explanatory and makes programming extremely simple. The all around LED signal offers visual control of the operating status even from a distance. The system assembles and installs in just minutes. With a pressure build-up of up to 6 bar it works reliably over a wide temperature range from -10 °C to +60 °C.

Fast, easy set up

perma STAR VARIO consists of a transparent LC unit filled with oil or grease, a powerful battery set, and a reusable drive unit. Just insert the battery, screw drive unit and LC unit together, push the button to enter the desired discharge period (1 – 12 months) and LC size (60, 120, 250 cm³) and the system is ready to go.

One lubrication system for all types of applications

perma STAR VARIO is suitable for indoor or outdoor applications with high or low ambient temperatures. The high pressure build-up to 6 bar makes it possible to install perma STAR VARIO at remote locations, away from dangerous areas, with extension tubes up to a length of 5 meters. Not only does this save time when the lubrication system is exchanged, but it also tremendously reduces the risk of workplace accidents. With its three different sizes and many possible settings, perma STAR VARIO is a preferred system for electric motors with very specific relubrication amounts. The all around LED signal light lets you monitor the operational status from a distance. The new design protects the drive unit from water and makes the system better suited for applications in moist and wet surroundings.

Environmentally friendly lubrication

perma STAR VARIO can be individually programmed to exactly meet the lubrication requirements of different applications. The system continuously discharges small lubricant amounts at specified intervals. This lowers lubricant consumption and prevents over-lubrication and lubricant spills. The reusable drive unit reduces maintenance costs and saves valuable resources. We are taking service a step further.

Our extensive perma accessory range includes connecting parts for just about all applications like electric motors, conveyor systems, pumps, fans and blowers. To make your start into perma automatic lubrication easier, we have developed special mounting sets. Our perma SELECT software helps you find the ideal lubrication system and the most suitable lubricant for your application. You can download it free of charge. Our team of lubrication experts will be glad to answer any questions, assist you with challenging applications, or visit you on site.

Technical data

Drive – reusable: Electromechanical
Power supply: TAR VARIO battery set 4.5 V
Discharge period: 1, 2, 3, … 12 months
Lubricant volume: 60 cm³, 120 cm³ or 250 cm³
Operating temperature: -10 °C to +60 °C
Pressure build-up: 6 bar
Protection class: IP 65
Lubricants: Oil / grease up to NLGI 2
Certifications: UL

perma-tec has been providing innovative and creative lubrication solutions for more than 50 years. Our single- and multi-point lubrication systems can be found in almost all types of industries and applications around the world.

perma-tec´s leadership in single-point lubrication is based on many patents and certifications. All perma products are developed, tested and manufactured in the company´s German headquarters and live up to the „Made in Germany“ quality.

With many years of experience and a network of subsidiaries and competent partners around the world we can offer our customers lubrication solutions that meet highest technical requirements.

Contact
perma-tec GmbH & Co. KG
Doris Bauer
Hammelburger Straße 21
97717 Euerdorf
Phone: +49 9704 609-3663
E-Mail: d.bauer@perma-tec.de
Url: http://www.perma-tec.com

Science Research Technology

BHS-Sonthofen: Mixers from Bavaria on the roof of the world

Mixing hydro dram concrete: Twin-shaft batch mixers deployed 3,700 m above sea level

BHS-Sonthofen: Mixers from Bavaria on the roof of the world

The six BHS-Sonthofen mixers are located in the building holding the batcher that feeds aggregates

Six twin-shaft batch mixers of type DKX 6.0 delivered by BHS-Sonthofen are producing the concrete needed to build the main embankment of the Dagu hydro dam undergoing construction near the Tibetan city of Zangmu. The construction site is located 3,700 m above sea level, making this the most elevated site ever for employing mixers from BHS. BHS-Sonthofen specially modified the mixers to meet the challenges they are facing at this extreme altitude.

The first two mixers of type DKX 6.0 started producing the first batches of concrete on 12 July 2017. Two months later, Sinohydro No. 9 Engineering Company commissioned four more units. The mixers will produce approximately three million tons of roller compacted concrete (RCC) over the course of the dam“s construction, which is scheduled for completion in 2019. The complete facility, which comprises six mixers, is dimensioned to produce 160,000 m³ of hardened concrete per month.

The mixers are equipped with a coarse-grain mixing unit for processing grain sizes up to 160 mm, as is typical in hydro dam construction. This mixer type has proven its worth in numerous installations across the globe.

About 6 m³ of hardened concrete are discharged per batch at a rate of up to 48 cycles per hour, resulting in a total yield of up to 288 m³ of hardened concrete in one hour. The cycle times are short due to the intensive mixing of the concrete and the extra-large rotary valves at the underside of the mixing trough, which significantly speed up the discharge process.

Given the vast amount of concrete that needs to be processed, BHS-Sonthofen reinforced the mixing troughs with a tougher version of its 28-mm „Optilong“ wear tiles. The service life of these tiles is nearly twice as long as the diamond-shaped tiles commonly used in construction projects. The variable hardness of the individual tile rows ensures uniform abrasion across all wear zones.

BHS-Sonthofen even accounted for the remote location of the construction site: In order to prepare the machines for a potentially unstable grid, the company used special motor couplings. The hydrodynamic turbo couplings reduce mechanical as well as electrical load peaks. Thanks to this property, they have proven ideal for use in locations with critical grid fluctuations.

Also, since high-altitude air does not extract as much heat from the electric motors, BHS-Sonthofen equipped the mixers with special motors that feature type „H“ insulation.

The sheer remoteness of the construction site posed yet another challenge. The construction site in Tibet is nearly 4,000 km from Tianjin near Beijing, which is where BHS-Sonthofen“s Chinese subsidiary is situated. It took 20 days to transport the mixers across this distance.

The project:

Once completed, the Dagu dam will be 126 m tall with a dam crest measuring 385 m. The power plant will generate 640 MW of hydro energy.

The dam is part of a major project undertaken by the Chinese government to provide the eastern parts of the Tibetan Autonomous Region with electricity, all the way to remote villages. Multiple hydro dams are damming up the Yarlung Tsangpo, the Earth“s highest river. It crosses Tibet from west to east and continues through India, where it is called Brahmaputra.

About BHS-Sonthofen GmbH

BHS-Sonthofen GmbH is an owner-operated group of companies in the field of machinery and plant engineering based in Sonthofen, Germany. The company offers technical solutions for mechanical process technology, concentrating primarily on mixing, crushing, recycling and filtration. BHS-Sonthofen has a global presence, with more than 350 employees and several subsidiaries.

The Mixing Technology division produces batch and continuous mixers and offers the full range of process technology services for mixing applications. The twin-shaft batch mixer, which is considered a global benchmark in the concrete industry, is a key product.

Building companies use the mixers first and foremost to produce transport, precast, high-performance and hydro dam concrete or concrete paving blocks. BHS mixers are also highly suited for mixing dry mortar, cement and sand-lime products or for processing clay-and-rock mixtures.

They are widely used for processing mineral mixes, landfill substances, fly ash, dusts or other bulk materials, or for the conditioning of sludges and the production of suspensions. The latter is often done in the context of backfilling mines or depositing mineral waste.

For further information, please visit: www.bhs-sonthofen.de

Company-Contact
BHS-Sonthofen GmbH
Roland Schmid
An der Eisenschmelze 47
D-87527 Sonthofen, Germany
Phone: +49 8321 6099-231
E-Mail: press@bhs-sonthofen.de
Url: http://www.bhs-sonthofen.de

Press
VIP Kommunikation
Regina Reinhardt
Dennewartstr. 25-27
52068 Aachen, Germany
Phone: +49.241.89468-24
Fax: +49.241.89468-44
E-Mail: reinhardt@vip-kommunikation.de
Url: http://www.vip-kommunikation.de